©The Author(s) 2005.
World J Gastroenterol. Jul 7, 2005; 11(25): 3871-3876
Published online Jul 7, 2005. doi: 10.3748/wjg.v11.i25.3871
Published online Jul 7, 2005. doi: 10.3748/wjg.v11.i25.3871
Table 1 Clinicopathological parameters of 52 patients with colorectal carcinoma
| Clinicopathological parameters | Numbers(%) | |
| Gender | Male | 29 (55.8) |
| Female | 23 (44.2) | |
| Age (yr) | Range | 26-87 |
| Mean | 56.4 | |
| Median | 60.0 | |
| Primary site | Rectum | 15 (28.8) |
| Sigmoid colon | 6 (11.5) | |
| Colon | 31 (59.6) | |
| Duke’s stage | Duke’s A | 7 (13.5) |
| Duke’s B | 23 (44.2) | |
| Duke’s C | 15 (28.8) | |
| Duke’s D | 7 (13.5) | |
| Tumor size | ≥ 5 cm | 23 (44.2) |
| < 5 cm | 29 (55.8) | |
| Histological grade | Well differentiated tumor | 9 (17.3) |
| Moderately differentiated tumor | 32 (61.5) | |
| Poorly differentiated tumor | 11 (21.2) | |
| CEA | ≥ 5 mg/L | 15 (28.8) |
| < 5 mg/L | 37 (71.2) | |
- Citation: Zheng YF, Yang J, Zhao XJ, Feng B, Kong HW, Chen YJ, Lv S, Zheng MH, Xu GW. Urinary nucleosides as biological markers for patients with colorectal cancer. World J Gastroenterol 2005; 11(25): 3871-3876
- URL: https://www.wjgnet.com/1007-9327/full/v11/i25/3871.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i25.3871